Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Medrobotics Announces Launch of the Flex Retractor

Medrobotics Corp., a surgical products company with core competencies in medical robotics, has announced the market release of its Flex Retractor in the U.S. and Europe.

The Flex Retractor is lightweight and easy to handle and position. It has been designed to facilitate exposure in advanced transoral surgeries, including robotic and laser microsurgery procedures. Medrobotics has incorporated an industry first axial tongue blade rotation capability, which allows surgeons to create unprecedented exposure in certain procedures involving the base of tongue.

Dr. Marshall Strome, M.D., Professor and Chairman Emeritus, Cleveland Clinic Head and Neck Institute and Co-Chair of Medrobotics Medical Advisory Board, said, “The Flex Retractor is a significant advance for transoral surgery. With its unique adjustability and ease of use, the Flex Retractor offers head and neck surgeons the confidence that they can efficiently achieve the exposure that they need for advanced transoral procedures.”

Medrobotics received the CE mark for the Flex Retractor which permits distribution in the European Union. The Company has met all applicable FDA requirements to distribute the Flex Retractor in the U.S. where it is a class I device and exempt from FDA’s premarket notification process.



Submit a Comment

Your email address will not be published. Required fields are marked *